{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:29:44Z","timestamp":1789669784539,"version":"4.0.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["(C) JP21K06783"],"award-info":[{"award-number":["(C) JP21K06783"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["(B) JP22K15668"],"award-info":[{"award-number":["(B) JP22K15668"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00535-023-02016-4","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T01:01:48Z","timestamp":1688605308000},"page":"868-882","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Ferroptosis in the colon epithelial cells as a therapeutic target for ulcerative colitis"],"prefix":"10.1007","volume":"58","author":[{"given":"Akihito","family":"Yokote","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Imazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Umeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Fuyuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Matsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohta","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanari","family":"Kitazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8256-2549","authenticated-orcid":false,"given":"Takehiro","family":"Torisu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"key":"2016_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","volume":"142","author":"NA Molodecky","year":"2012","unstructured":"Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46-54.e42 (quiz e30).","journal-title":"Gastroenterology"},{"key":"2016_CR2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1053\/j.gastro.2020.08.064","volume":"160","author":"EL Barnes","year":"2021","unstructured":"Barnes EL, Loftus EV Jr., Kappelman MD. Effects of race and ethnicity on diagnosis and management of inflammatory bowel diseases. Gastroenterology. 2021;160:677\u201389.","journal-title":"Gastroenterology"},{"key":"2016_CR3","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1053\/j.gastro.2017.11.024","volume":"154","author":"M Naganuma","year":"2018","unstructured":"Naganuma M, Sugimoto S, Mitsuyama K, et al. Efficacy of Indigo naturalis in a multicenter randomized controlled trial of patients with ulcerative colitis. Gastroenterology. 2018;154:935\u201347.","journal-title":"Gastroenterology"},{"key":"2016_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241337","volume":"15","author":"K Uchiyama","year":"2020","unstructured":"Uchiyama K, Takami S, Suzuki H, et al. Efficacy and safety of short-term therapy with indigo naturalis for ulcerative colitis: an investigator-initiated multicenter double-blind clinical trial. PLoS ONE. 2020;15: e0241337.","journal-title":"PLoS ONE"},{"key":"2016_CR5","doi-asserted-by":"publisher","first-page":"260","DOI":"10.5217\/ir.2021.00124","volume":"20","author":"Y Matsuno","year":"2022","unstructured":"Matsuno Y, Torisu T, Umeno J, et al. One-year clinical efficacy and safety of indigo naturalis for active ulcerative colitis: a real-world prospective study. Intest Res. 2022;20:260\u20138.","journal-title":"Intest Res"},{"key":"2016_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000444217","volume":"93","author":"S Sugimoto","year":"2016","unstructured":"Sugimoto S, Naganuma M, Kiyohara H, et al. Clinical efficacy and safety of oral Qing-Dai in patients with ulcerative colitis: a single-center open-label prospective study. Digestion. 2016;93:193\u2013201.","journal-title":"Digestion"},{"key":"2016_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/jgh.14823","volume":"35","author":"Y Matsuno","year":"2020","unstructured":"Matsuno Y, Hirano A, Torisu T, et al. Short-term and long-term outcomes of indigo naturalis treatment for inflammatory bowel disease. J Gastroenterol Hepatol. 2020;35:412\u20137.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"2016_CR8","doi-asserted-by":"publisher","first-page":"e000813","DOI":"10.1136\/bmjgast-2021-000813","volume":"8","author":"JP Saiki","year":"2021","unstructured":"Saiki JP, Andreasson JO, Grimes KV, et al. Treatment-refractory ulcerative colitis responsive to indigo naturalis. BMJ Open Gastroenterol. 2021;8(1):e000813.","journal-title":"BMJ Open Gastroenterol."},{"key":"2016_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00535-019-01625-2","volume":"55","author":"M Naganuma","year":"2020","unstructured":"Naganuma M, Sugimoto S, Fukuda T, et al. Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study. J Gastroenterol. 2020;55:169\u201380.","journal-title":"J Gastroenterol"},{"key":"2016_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1164\/rccm.202009-3385LE","volume":"203","author":"T Hiraide","year":"2021","unstructured":"Hiraide T, Teratani T, Uemura S, et al. Pulmonary arterial hypertension caused by AhR signal activation protecting against colitis. Am J Respir Crit Care Med. 2021;203:385\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"2016_CR11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00535-019-01591-9","volume":"54","author":"M Naganuma","year":"2019","unstructured":"Naganuma M, Sugimoto S, Suzuki H, et al. Adverse events in patients with ulcerative colitis treated with indigo naturalis: a Japanese nationwide survey. J Gastroenterol. 2019;54:891\u20136.","journal-title":"J Gastroenterol"},{"key":"2016_CR12","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s00535-016-1292-z","volume":"52","author":"S Kawai","year":"2017","unstructured":"Kawai S, Iijima H, Shinzaki S, et al. Indigo naturalis ameliorates murine dextran sodium sulfate-induced colitis via aryl hydrocarbon receptor activation. J Gastroenterol. 2017;52:904\u201319.","journal-title":"J Gastroenterol"},{"key":"2016_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bcp.2018.07.032","volume":"155","author":"KW Bock","year":"2018","unstructured":"Bock KW. From TCDD-mediated toxicity to searches of physiologic AHR functions. Biochem Pharmacol. 2018;155:419\u201324.","journal-title":"Biochem Pharmacol"},{"key":"2016_CR14","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3109\/10715762.2012.717692","volume":"46","author":"G Jena","year":"2012","unstructured":"Jena G, Trivedi PP, Sandala B. Oxidative stress in ulcerative colitis: an old concept but a new concern. Free Radic Res. 2012;46:1339\u201345.","journal-title":"Free Radic Res"},{"key":"2016_CR15","doi-asserted-by":"publisher","first-page":"9875298","DOI":"10.1155\/2016\/9875298","volume":"2016","author":"Z Wang","year":"2016","unstructured":"Wang Z, Li S, Cao Y, et al. Oxidative stress and carbonyl lesions in ulcerative colitis and associated colorectal cancer. Oxid Med Cell Longev. 2016;2016:9875298.","journal-title":"Oxid Med Cell Longev"},{"key":"2016_CR16","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1093\/ibd\/izab277","volume":"28","author":"Y Wan","year":"2022","unstructured":"Wan Y, Yang L, Jiang S, et al. Excessive apoptosis in ulcerative colitis: crosstalk between apoptosis, ROS, ER stress, and intestinal homeostasis. Inflamm Bowel Dis. 2022;28:639\u201348.","journal-title":"Inflamm Bowel Dis"},{"key":"2016_CR17","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"2016_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41419-020-2299-1","volume":"11","author":"M Xu","year":"2020","unstructured":"Xu M, Tao J, Yang Y, et al. Ferroptosis involves in intestinal epithelial cell death in ulcerative colitis. Cell Death Dis. 2020;11:86.","journal-title":"Cell Death Dis"},{"key":"2016_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13020-020-00406-x","volume":"15","author":"Y Qi-Yue","year":"2020","unstructured":"Qi-Yue Y, Ting Z, Ya-Nan H, et al. From natural dye to herbal medicine: a systematic review of chemical constituents, pharmacological effects and clinical applications of indigo naturalis. Chin Med. 2020;15:127.","journal-title":"Chin Med"},{"key":"2016_CR20","doi-asserted-by":"publisher","first-page":"W147","DOI":"10.1093\/nar\/gkw419","volume":"44","author":"S Babicki","year":"2016","unstructured":"Babicki S, Arndt D, Marcu A, et al. Heatmapper: web-enabled heat mapping for all. Nucleic Acids Res. 2016;44:W147\u201353.","journal-title":"Nucleic Acids Res"},{"key":"2016_CR21","doi-asserted-by":"publisher","first-page":"D687","DOI":"10.1093\/nar\/gkab1028","volume":"50","author":"M Gillespie","year":"2022","unstructured":"Gillespie M, Jassal B, Stephan R, et al. The reactome pathway knowledgebase 2022. Nucleic Acids Res. 2022;50:D687\u201392.","journal-title":"Nucleic Acids Res"},{"key":"2016_CR22","unstructured":"Bedre R, (2020) reneshbedre\/bioinfokit: Bioinformatics data analysis and visualization toolkit. Zenodo"},{"key":"2016_CR23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2[-Delta Delta C (T)] method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"2016_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013;53:401\u201326.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2016_CR25","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1089\/ars.2010.3216","volume":"13","author":"N Wakabayashi","year":"2010","unstructured":"Wakabayashi N, Slocum SL, Skoko JJ, et al. When NRF2 talks, who\u2019s listening? Antioxid Redox Signal. 2010;13:1649\u201363.","journal-title":"Antioxid Redox Signal"},{"key":"2016_CR26","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1002\/jcp.29219","volume":"235","author":"P Shaw","year":"2020","unstructured":"Shaw P, Chattopadhyay A. Nrf2-ARE signaling in cellular protection: mechanism of action and the regulatory mechanisms. J Cell Physiol. 2020;235:3119\u201330.","journal-title":"J Cell Physiol"},{"key":"2016_CR27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/toxsci\/kfp115","volume":"111","author":"RL Yeager","year":"2009","unstructured":"Yeager RL, Reisman SA, Aleksunes LM, et al. Introducing the \u201cTCDD-inducible AhR-Nrf2 gene battery.\u201d Toxicol Sci. 2009;111:238\u201346.","journal-title":"Toxicol Sci"},{"key":"2016_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41467-018-07859-7","volume":"10","author":"R Singh","year":"2019","unstructured":"Singh R, Chandrashekharappa S, Bodduluri SR, et al. Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway. Nat Commun. 2019;10:89.","journal-title":"Nat Commun"},{"key":"2016_CR29","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.freeradbiomed.2020.11.018","volume":"163","author":"R Tocmo","year":"2021","unstructured":"Tocmo R, Le B, Heun A, et al. Prenylated xanthones from mangosteen (Garcinia mangostana) activate the AhR and Nrf2 pathways and protect intestinal barrier integrity in HT-29 cells. Free Radic Biol Med. 2021;163:102\u201315.","journal-title":"Free Radic Biol Med"},{"key":"2016_CR30","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1089\/ars.2017.7342","volume":"29","author":"C Tonelli","year":"2018","unstructured":"Tonelli C, Chio IIC, Tuveson DA. Transcriptional regulation by Nrf2. Antioxid Redox Signal. 2018;29:1727\u201345.","journal-title":"Antioxid Redox Signal"},{"key":"2016_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2013.07.036","volume":"66","author":"J Lu","year":"2014","unstructured":"Lu J, Holmgren A. The thioredoxin antioxidant system. Free Radic Biol Med. 2014;66:75\u201387.","journal-title":"Free Radic Biol Med"},{"key":"2016_CR32","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","volume":"73","author":"A Loboda","year":"2016","unstructured":"Loboda A, Damulewicz M, Pyza E, et al. Role of Nrf2\/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci. 2016;73:3221\u201347.","journal-title":"Cell Mol Life Sci"},{"key":"2016_CR33","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.redox.2014.09.002","volume":"2","author":"A Ramesh","year":"2014","unstructured":"Ramesh A, Varghese SS, Doraiswamy J, et al. Role of sulfiredoxin in systemic diseases influenced by oxidative stress. Redox Biol. 2014;2:1023\u20138.","journal-title":"Redox Biol"},{"key":"2016_CR34","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185:2401\u201321.","journal-title":"Cell"},{"key":"2016_CR35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death Nexus linking metabolism, redox biology, and disease. Cell. 2017;171:273\u201385.","journal-title":"Cell"},{"key":"2016_CR36","doi-asserted-by":"publisher","first-page":"12890","DOI":"10.1038\/s41598-021-92369-8","volume":"11","author":"L Chen","year":"2021","unstructured":"Chen L, Na R, Danae McLane K, et al. Overexpression of ferroptosis defense enzyme Gpx4 retards motor neuron disease of SOD1G93A mice. Sci Rep. 2021;11:12890.","journal-title":"Sci Rep"},{"key":"2016_CR37","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41419-021-04284-5","volume":"12","author":"Y Shou","year":"2021","unstructured":"Shou Y, Yang L, Yang Y, et al. Inhibition of keratinocyte ferroptosis suppresses psoriatic inflammation. Cell Death Dis. 2021;12:1009.","journal-title":"Cell Death Dis"},{"key":"2016_CR38","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1111\/jgh.14642","volume":"34","author":"Y Kobayashi","year":"2019","unstructured":"Kobayashi Y, Ohfuji S, Kondo K, et al. Association between dietary iron and zinc intake and development of ulcerative colitis: a case-control study in Japan. J Gastroenterol Hepatol. 2019;34:1703\u201310.","journal-title":"J Gastroenterol Hepatol"},{"key":"2016_CR39","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1046\/j.1365-2036.2000.00828.x","volume":"14","author":"AD Millar","year":"2000","unstructured":"Millar AD, Rampton DS, Blake DR. Effects of iron and iron chelation in vitro on mucosal oxidant activity in ulcerative colitis. Aliment Pharmacol Ther. 2000;14:1163\u20138.","journal-title":"Aliment Pharmacol Ther"},{"key":"2016_CR40","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ng.3359","volume":"47","author":"JZ Liu","year":"2015","unstructured":"Liu JZ, van Sommeren S, Huang H, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47:979\u201386.","journal-title":"Nat Genet"},{"key":"2016_CR41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/10408444.2020.1773759","volume":"50","author":"S Safe","year":"2020","unstructured":"Safe S, Jayaraman A, Chapkin RS. Ah receptor ligands and their impacts on gut resilience: structure-activity effects. Crit Rev Toxicol. 2020;50:463\u201373.","journal-title":"Crit Rev Toxicol"},{"key":"2016_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110773","volume":"39","author":"Y Yoshimatsu","year":"2022","unstructured":"Yoshimatsu Y, Sujino T, Miyamoto K, et al. Aryl hydrocarbon receptor signals in epithelial cells govern the recruitment and location of Helios(+) Tregs in the gut. Cell Rep. 2022;39: 110773.","journal-title":"Cell Rep"},{"key":"2016_CR43","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1111\/bph.12205","volume":"169","author":"M Rouse","year":"2013","unstructured":"Rouse M, Singh NP, Nagarkatti PS, et al. Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells. Br J Pharmacol. 2013;169:1305\u201321.","journal-title":"Br J Pharmacol"},{"key":"2016_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023522","volume":"6","author":"NP Singh","year":"2011","unstructured":"Singh NP, Singh UP, Singh B, et al. Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis. PLoS ONE. 2011;6: e23522.","journal-title":"PLoS ONE"},{"key":"2016_CR45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature06880","volume":"453","author":"FJ Quintana","year":"2008","unstructured":"Quintana FJ, Basso AS, Iglesias AH, et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature. 2008;453:65\u201371.","journal-title":"Nature"},{"key":"2016_CR46","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cotox.2017.01.006","volume":"2","author":"MS Denison","year":"2017","unstructured":"Denison MS, Faber SC. And now for something completely different: diversity in ligand-dependent activation of Ah receptor responses. Curr Opin Toxicol. 2017;2:124\u201331.","journal-title":"Curr Opin Toxicol"},{"key":"2016_CR47","doi-asserted-by":"publisher","first-page":"20340","DOI":"10.1074\/jbc.M412081200","volume":"280","author":"W Miao","year":"2005","unstructured":"Miao W, Hu L, Scrivens PJ, et al. Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway: direct cross-talk between phase I and II drug-metabolizing enzymes. J Biol Chem. 2005;280:20340\u20138.","journal-title":"J Biol Chem"},{"key":"2016_CR48","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2103629","volume":"385","author":"MG Lebwohl","year":"2021","unstructured":"Lebwohl MG, Stein Gold L, Strober B, et al. Phase 3 trials of tapinarof cream for plaque psoriasis. N Engl J Med. 2021;385:2219\u201329.","journal-title":"N Engl J Med"},{"key":"2016_CR49","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.bbagen.2008.06.003","volume":"1780","author":"CH Lillig","year":"2008","unstructured":"Lillig CH, Berndt C, Holmgren A. Glutaredoxin systems. Biochim Biophys Acta. 2008;1780:1304\u201317.","journal-title":"Biochim Biophys Acta"},{"key":"2016_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201800311","volume":"19","author":"GC Forcina","year":"2019","unstructured":"Forcina GC, Dixon SJ. GPX4 at the crossroads of lipid homeostasis and ferroptosis. Proteomics. 2019;19: e1800311.","journal-title":"Proteomics"},{"key":"2016_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23: 101107.","journal-title":"Redox Biol"},{"key":"2016_CR52","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 2016;26:165\u201376.","journal-title":"Trends Cell Biol"},{"key":"2016_CR53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Kagan VE, Mao G, Qu F, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13:81\u201390.","journal-title":"Nat Chem Biol"},{"issue":"Suppl 1","key":"2016_CR54","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000505368","volume":"101","author":"P Schreiner","year":"2020","unstructured":"Schreiner P, Martinho-Grueber M, Studerus D, et al. Nutrition in inflammatory bowel disease. Digestion. 2020;101(Suppl 1):120\u201335.","journal-title":"Digestion"},{"key":"2016_CR55","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1053\/j.gastro.2010.07.065","volume":"139","author":"PS de Silva","year":"2010","unstructured":"de Silva PS, Olsen A, Christensen J, et al. An association between dietary arachidonic acid, measured in adipose tissue, and ulcerative colitis. Gastroenterology. 2010;139:1912\u20137.","journal-title":"Gastroenterology"},{"key":"2016_CR56","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1136\/gut.2008.169078","volume":"58","author":"A Tjonneland","year":"2009","unstructured":"Tjonneland A, Overvad K, Bergmann MM, et al. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut. 2009;58:1606\u201311.","journal-title":"Gut"},{"key":"2016_CR57","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/gut.42.4.485","volume":"42","author":"B Sido","year":"1998","unstructured":"Sido B, Hack V, Hochlehnert A, et al. Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease. Gut. 1998;42:485\u201392.","journal-title":"Gut"},{"key":"2016_CR58","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jphs.2020.01.003","volume":"142","author":"K Ozawa","year":"2020","unstructured":"Ozawa K, Mori D, Hatanaka A, et al. Comparison of the anti-colitis activities of Qing Dai\/Indigo naturalis constituents in mice. J Pharmacol Sci. 2020;142:148\u201356.","journal-title":"J Pharmacol Sci"},{"key":"2016_CR59","first-page":"215","volume":"71","author":"N Stasiak","year":"2014","unstructured":"Stasiak N, Kuku\u0142a-Koch W, G\u0142owniak K. Modern industrial and pharmacological applications of indigo dye and its derivatives\u2013a review. Acta Pol Pharm. 2014;71:215\u201321.","journal-title":"Acta Pol Pharm"},{"key":"2016_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109235","volume":"35","author":"C Xu","year":"2021","unstructured":"Xu C, Sun S, Johnson T, et al. The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain treg cell activation and suppression of antitumor immunity. Cell Rep. 2021;35: 109235.","journal-title":"Cell Rep"},{"key":"2016_CR61","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1053\/j.gastro.2020.01.006","volume":"158","author":"JD Feuerstein","year":"2020","unstructured":"Feuerstein JD, Isaacs KL, Schneider Y, et al. AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis. Gastroenterology. 2020;158:1450\u201361.","journal-title":"Gastroenterology"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-023-02016-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-023-02016-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-023-02016-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T02:06:03Z","timestamp":1700705163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-023-02016-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["2016"],"URL":"https:\/\/doi.org\/10.1007\/s00535-023-02016-4","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,6]]},"assertion":[{"value":"17 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}